1.01
price down icon1.08%   -0.011
after-market アフターアワーズ: .99 -0.02 -1.98%
loading
前日終値:
$1.021
開ける:
$0.99
24時間の取引高:
77,166
Relative Volume:
0.45
時価総額:
$32.94M
収益:
-
当期純損益:
-
株価収益率:
-2.9015
EPS:
-0.3481
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+32.81%
1か月 パフォーマンス:
+32.89%
6か月 パフォーマンス:
-18.55%
1年 パフォーマンス:
-65.76%
1日の値動き範囲:
Value
$0.98
$1.0846
1週間の範囲:
Value
$0.76
$1.24
52週間の値動き範囲:
Value
$0.5714
$3.70

Akari Therapeutics Plc Adr Stock (AKTX) Company Profile

Name
名前
Akari Therapeutics Plc Adr
Name
セクター
Healthcare (1147)
Name
電話
(646) 350-0702
Name
住所
22 BOSTON WHARF ROAD, BOSTON
Name
職員
12
Name
Twitter
@AkariTX
Name
次回の収益日
2024-04-29
Name
最新のSEC提出書
Name
AKTX's Discussions on Twitter

AKTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.01 33.30M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Akari Therapeutics Plc Adr Stock (AKTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 開始されました Maxim Group Buy
2019-01-04 アップグレード B. Riley FBR Neutral → Buy
2018-02-08 開始されました B. Riley FBR, Inc. Neutral
2017-09-22 アップグレード William Blair Mkt Perform → Outperform
2017-05-31 アップグレード Chardan Capital Markets Sell → Neutral
2017-04-17 繰り返されました Chardan Capital Markets Sell
2016-07-11 開始されました Chardan Capital Markets Sell
すべてを表示

Akari Therapeutics Plc Adr (AKTX) 最新ニュース

pulisher
Sep 25, 2025

Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews

Sep 25, 2025
pulisher
Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer By Investing.com - Investing.com South Africa

Sep 24, 2025
pulisher
Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

First Potential Treatment for AR-V7 Driven Prostate Cancer: Akari's PH1 Shows Dual Action in Studies - Stock Titan

Sep 24, 2025
pulisher
Sep 22, 2025

Can momentum traders help lift Tripadvisor Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com

Sep 22, 2025
pulisher
Sep 19, 2025

Analyzing PRA Group Inc. with risk reward ratio chartsJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Institutional scanner results for ANSYS Inc.Entry Point & Verified Technical Trade Signals - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Does SRTY fit your quant trading modelPortfolio Gains Report & Stock Timing and Entry Methods - newser.com

Sep 19, 2025
pulisher
Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach By Investing.com - Investing.com South Africa

Sep 17, 2025
pulisher
Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach - Investing.com

Sep 17, 2025
pulisher
Sep 17, 2025

Revolutionary Spliceosome Cancer Treatment: Akari Files Patent for First-in-Class ADC Platform Technology - Stock Titan

Sep 17, 2025
pulisher
Sep 16, 2025

Is BSIIU stock reversal real or fake2025 Market Overview & Verified Swing Trading Watchlists - newser.com

Sep 16, 2025
pulisher
Sep 14, 2025

Security Solutions Inc.2025 Market Outlook & Smart Money Movement Tracker - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Applying big data sentiment scoring on HLITJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Sep 14, 2025
pulisher
Sep 05, 2025

Novel ADC Developer Akari Therapeutics to Showcase Pipeline at Major Healthcare Conference - Stock Titan

Sep 05, 2025
pulisher
Sep 03, 2025

Next-Gen Cancer Drug Developer Akari Therapeutics Showcases Novel IO-Payload ADC Platform - Stock Titan

Sep 03, 2025
pulisher
Aug 30, 2025

Advanced analytics toolkit walkthrough for Educational Development CorporationShare Buyback & Free Expert Approved Momentum Trade Ideas - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

What high frequency data says about MGTXOil Prices & Free Technical Confirmation Trade Alerts - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Using AI based signals to follow BWXT2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Analyzing recovery setups for Guardian Pharmacy Services Inc. investorsMarket Volume Report & Weekly High Return Stock Forecasts - Newser

Aug 28, 2025
pulisher
Aug 21, 2025

Akari Therapeutics completes $2.8 million note offering and extends warrant terms - Investing.com

Aug 21, 2025
pulisher
Aug 19, 2025

Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan

Aug 19, 2025
pulisher
Aug 14, 2025

Cancer Drug Developer Akari Therapeutics Showcases Pipeline at Webull Biotech Conference - Stock Titan

Aug 14, 2025
pulisher
Aug 09, 2025

Is BACQR still worth holding after the dipEquity Market Return Forecast Model Update - Newser

Aug 09, 2025
pulisher
Jul 31, 2025

Insider Stock Buying Reaches US$1.79m On Akari Therapeutics - Sahm

Jul 31, 2025
pulisher
Jul 29, 2025

Akari Therapeutics Reveals Breakthrough Progress in Cancer-Fighting Drug Development - Stock Titan

Jul 29, 2025
pulisher
Jul 23, 2025

Akari Therapeutics advances cancer-fighting ADC technology with PH1 payload - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Revolutionary Cancer Drug PH1 Targets KRAS, BRAF While Activating Immune System Against Tumors - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Akari Therapeutics CEO Shares Exclusive Insights on Next-Gen Cancer Drug Development Strategy - Stock Titan

Jul 22, 2025
pulisher
Jul 11, 2025

INKT Stock Quote Price and Forecast - CNN

Jul 11, 2025
pulisher
Jul 01, 2025

Akari Therapeutics shareholders approve equity plan increase and director elections - Investing.com

Jul 01, 2025
pulisher
Jun 25, 2025

Akari Therapeutics Expands Global IP Portfolio: Key Patent Win for Cancer Drug Platform in India - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

AKTX CEO buys 10,000 ADS at $1.20 in Form 4 insider filing - Stock Titan

Jun 24, 2025
pulisher
Jun 18, 2025

Akari Therapeutics secures Indian patent for cancer drug payload - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Akari's Revolutionary Cancer Drug Technology Wins Key Patent in India's 2.08M Patient Market - Stock Titan

Jun 18, 2025
pulisher
May 29, 2025

Oncology Deal Veteran Mark Kubik Joins Akari Therapeutics to Accelerate ADC Pipeline Growth - Stock Titan

May 29, 2025
pulisher
May 22, 2025

Akari Therapeutics CEO Reveals Latest Oncology ADC Developments at Major Webull Investor Event - Stock Titan

May 22, 2025
pulisher
May 17, 2025

Akari Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 17, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business - Investing.com

May 01, 2025
pulisher
Apr 22, 2025

Akari Therapeutics' New CEO Reveals Future Roadmap: Key Insights from First Leadership Address - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Akari Therapeutics Advances ADC Development Amid Financial Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Akari Therapeutics Transforms: Next-Gen Cancer Drug Shows Promise Amid 2024 Results - Stock Titan

Apr 16, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down - Investing.com

Mar 20, 2025
pulisher
Mar 03, 2025

Akari Therapeutics secures $7.6 million in private placement - Investing.com

Mar 03, 2025
pulisher
Feb 25, 2025

Acciones de Alibaba (BABA) caen tras medidas de Trump para frenar inversiones chinas en tecnología - Yahoo Finanzas

Feb 25, 2025
pulisher
Feb 19, 2025

Citi reveló que Ecopetrol ha publicado la guía de sus resultados para el cuarto trimestre de 2024 - Yahoo Finanzas

Feb 19, 2025
pulisher
Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024
pulisher
Sep 17, 2024

Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics - Stock Titan

Sep 17, 2024
pulisher
Jun 19, 2024

Riesgos y oportunidades sobre el futuro de la cotización de YPF - Yahoo Finanzas

Jun 19, 2024

Akari Therapeutics Plc Adr (AKTX) 財務データ

Akari Therapeutics Plc Adr (AKTX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):